Exciting Presentation by Picard Medical, Inc. at a Renowned Conference
Picard Medical, Inc. is making headlines as the company prepares for an important in-person presentation at a major global investment conference. This event is expected to showcase the innovative advancements in heart technology, led by the Chief Executive Officer, Patrick NJ Schnegelsberg.
Details of the Conference Presentation
This year, Picard Medical's presentation is highlighted as part of the 27th Annual Global Investment Conference, organized by H.C. Wainwright. The conference runs from September 8 to 10 at a prestigious hotel. Attendees will witness firsthand what Picard Medical has to offer to the healthcare sector.
Key Presentation Times and Format
The presentation is scheduled for September 10 at 1:30 PM. It will be conducted in a live format, allowing both in-person attendees and remote viewers to engage with the content presented by Picard Medical. This structure aims to maximize audience reach and interaction, an essential factor for effective engagement.
About Picard Medical, Inc.
Picard Medical is dedicated to revolutionizing heart care. As the parent company of SynCardia Systems, LLC, it leads the industry with its pioneering total artificial heart technology designed for patients suffering from end-stage heart failure. With FDA and Health Canada approvals, their SynCardia Total Artificial Heart (STAH) is a remarkable achievement in medical technology.
Global Impact of SynCardia Technology
Since its launch, SynCardia has successfully performed over 2,100 implants across 27 countries, establishing it as the most widely used total artificial heart in the world. This technology has been a beacon of hope for many patients in dire need of heart transplants, pushing the boundaries of what is possible in cardiac care.
Advancements in Heart Technology
Picard Medical is at the forefront of continuing innovations in heart technology. The SynCardia Total Artificial Heart has become synonymous with reliability and patient care efficacy, leading to improvements in the quality of life for patients with severe heart conditions.
Investor Engagement and Communication
For investors and stakeholders interested in the groundbreaking technologies around artificial hearts, the upcoming presentation will provide insights into future possibilities. The emphasis on live interactions and Q&A sessions during the presentation signifies Picard Medical’s commitment to keeping investors informed and engaged with the progressing landscape of cardiac solutions.
Contact Information for Further Inquiries
For more information regarding the investment conference or general inquiries about Picard Medical, interested parties are encouraged to reach out directly to the company’s investor relations team. Eric Ribner, Managing Director at LifeSci Advisors LLC, is available for discussions regarding investor matters. Brittany Lanza, the contact for general media inquiries, is also reachable for those looking to learn more about the company’s latest innovations.
Frequently Asked Questions
What is Picard Medical, Inc.?
Picard Medical is a healthcare company focused on developing heart-related technologies, including the total artificial heart.
Who will present at the conference?
Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical, will lead the presentation.
When is the presentation scheduled?
The presentation is set for September 10 at 1:30 PM.
Where is the event taking place?
The presentation will be at the H.C. Wainwright Annual Global Investment Conference.
How can I find more information about the company’s technologies?
More information can be found on the Picard Medical website or by contacting their investor relations team.
